−6.55 M USD
2.01 M USD
752.29 M
About NuGene International, Inc.
Sector
Industry
CEO
David Štybr
Website
Headquarters
New York
Founded
2013
FIGI
BBG005YQJ3N1
Livento Group, Inc. focuses on acquisition and development of companies with disruptive business models in film, content, and technology sectors. It engages in production of premium film and television content for international audiences across multiple genres under brand BOXO Productions. The firm is involved in the artificial intelligence and machine learning technology business and real estate finance and development activities. Livento Group was founded by David Stybr on October 30, 2013 and is headquartered in New York, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NUGN is 0.0034 USD — it hasn't changed in the past 24 hours. Watch NuGene International, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NuGene International, Inc. stocks are traded under the ticker NUGN.
NUGN stock has fallen by −51.43% compared to the previous week, the month change is a 13.33% rise, over the last year NuGene International, Inc. has showed a −57.50% decrease.
NUGN reached its all-time high on Feb 27, 2015 with the price of 5.0000 USD, and its all-time low was 0.0001 USD and was reached on Mar 7, 2018. View more price dynamics on NUGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NUGN stock is 29.63% volatile and has beta coefficient of −1.04. Track NuGene International, Inc. stock price on the chart and check out the list of the most volatile stocks — is NuGene International, Inc. there?
Today NuGene International, Inc. has the market capitalization of 2.64 M, it has decreased by −51.43% over the last week.
Yes, you can track NuGene International, Inc. financials in yearly and quarterly reports right on TradingView.
NUGN net income for the last quarter is −409.93 K USD, while the quarter before that showed 262.79 K USD of net income which accounts for −255.99% change. Track more NuGene International, Inc. financial stats to get the full picture.
No, NUGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 11.00 employees. See our rating of the largest employees — is NuGene International, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NuGene International, Inc. EBITDA is 394.67 K USD, and current EBITDA margin is −234.14%. See more stats in NuGene International, Inc. financial statements.
Like other stocks, NUGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NuGene International, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NuGene International, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NuGene International, Inc. stock shows the strong sell signal. See more of NuGene International, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.